Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now displayed on the page, replacing the previous Revision: v3.6.3. This indicates a minor platform update with no changes to the study details or visible content.
    Difference
    0.1%
    Check dated 2026-07-27T06:19:21.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now displays an updated revision tag (Revision: v3.6.3), replacing the previous Revision: v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-05T15:37:55.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    A new revision tag (v3.6.2) was added and the previous tag (v3.6.0) removed, indicating a platform software update.
    Difference
    0.1%
    Check dated 2026-06-28T08:43:01.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Recruitment status now shows no more participants; new user guidance sections were added, and the Intervention/Treatment header formatting was updated to reflect the current structure of the study details.
    Difference
    0.4%
    Check dated 2026-06-14T05:14:17.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The study record shows a new revision (v3.5.5) replacing the previous revision (v3.5.4), indicating an updated page version rather than new study data.
    Difference
    0.1%
    Check dated 2026-06-07T00:24:59.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.5.3 to v3.5.4, indicating a small build/version update.
    Difference
    0.1%
    Check dated 2026-05-16T09:30:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.